secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOADAPTIVES, INC. (BDPT)
CIK:        0001575142
Form:       8-K
Filed at:   2021-08-27T23:59:59+00:00
Accession:  0001640334-21-002041
Event type: other_material
Sentiment:  positive
Materiality: 0.35
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BioAdaptives partners with Stanford professor to study PluriPain for Gadolinium Deposition Disease pain
--------------------------------------------------------------------------------

- Collaboration with Stanford's Prof. Lorrin Koran to research PluriPain for pain relief in Gadolinium Deposition Disease.
- PluriPain used for analgesic/anti-inflammatory effects; no drug claims are made for treating the disease.
- Gadolinium Deposition Disease is a rare disorder caused by MRI contrast agent, leading to chronic pain.
- BioAdaptives' role is limited to providing PluriPain for Dr. Koran's research.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1575142/000164033421002041/0001640334-21-002041-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1575142/000164033421002041/bdpt_8k.htm
  HTML page:      https://secwatch.observer/filing/0001640334-21-002041

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer